Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Net Cash Flow (2023 - 2025)

Mangoceuticals' Net Cash Flow history spans 3 years, with the latest figure at $380307.0 for Q3 2025.

  • For Q3 2025, Net Cash Flow rose 191.46% year-over-year to $380307.0; the TTM value through Sep 2025 reached $407785.0, up 133.26%, while the annual FY2024 figure was -$670508.0, 1294.22% down from the prior year.
  • Net Cash Flow for Q3 2025 was $380307.0 at Mangoceuticals, up from $24336.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $3.2 million in Q1 2023 and bottomed at -$1.7 million in Q3 2023.
  • The 3-year median for Net Cash Flow is -$7077.0 (2024), against an average of -$24045.5.
  • The largest annual shift saw Net Cash Flow plummeted 122.7% in 2024 before it soared 191.46% in 2025.
  • A 3-year view of Net Cash Flow shows it stood at -$497741.0 in 2023, then surged by 98.58% to -$7077.0 in 2024, then skyrocketed by 5473.84% to $380307.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Net Cash Flow are $380307.0 (Q3 2025), $24336.0 (Q2 2025), and $10219.0 (Q1 2025).